AstraZeneca PLC stock price133.93 USD Previous Close146.88 USD Open148.3 USD Bid0 USD x 0 Ask0 USD x 0 Day's Range148.3 - 149.25 USD 52 Week Range104.5 - 153.1 USD Volume2.97K USD Avg. Volume4.8K USD Market Cap231.32B USD Beta (5Y Monthly)0.194636 ...
in-depth analysis, and powerful stock ratings. create free account bull or bear, seeking alpha is there markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. create free account azncf astrazeneca plc stock price & overview follow $ 134.86...
Market Cap $108B Current Price $86.72 NASDAQ: EXEL Exelixis Market Cap $8B Current Price $28.90 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services Making...
AZN | Complete AstraZeneca PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AstraZeneca PLC stock news, updates & related news. Find out why AstraZeneca PLC's (AZN) news sentiment is 13.34% more negative in relation to stocks in the Healthcare sector.
Price Change SPX S&P 500 DJIA Dow Jones NDX Nasdaq 100 BTC-USD Bitcoin More Trending Stocks > Latest News Feed Titan Machinery (TITN) Is an Attractive Value for the Patient Investor 47m ago TITN Why Urban Outfitters (URBN) Stock Has Jumped 37% In the Past Week ...
Eli Lilly has a Zacks Rank #1 (Strong Buy) currently. You can seethe complete list of today’s Zacks #1 Rank stocks here The Zacks Consensus Estimate for Lilly’s 2024 EPS has risen from $13.79 to $16.49 per share over the past 60 days. The stock has risen 52.2% year to date. ...
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources...
from AstraZeneca, or another acquirer,” he wrote in a Saturday note. “This is such a scarce and high-quality asset that in this instance, the final transaction price may need to reach $200 to satisfy Alexion’s shareholders, or to be based more in cash, rather than predominantly stock...
representing a 97% premium to Fusion’s closing stock price on Monday. Shareholders of the radiopharmaceutical company could get even more. The deal includes a contingent value right that will pay an additional $3 per share upon achievement of a regulatory milestone. That pa...